Cargando…

Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study

BACKGROUND: The treatment of multisystem inflammatory syndrome in children unresponsive to first-line therapies (IVIG and/or steroids) is challenging. The effectiveness of IL-1 receptor antagonist, anakinra, is debated. PATIENTS AND METHODS: We conducted an anonymous retrospective multicenter study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Licciardi, Francesco, Covizzi, Carlotta, Dellepiane, Marta, Olivini, Nicole, Mastrolia, Maria Vincenza, Lo Vecchio, Andrea, Monno, Viviana, Tardi, Maria, Mauro, Angela, Alessio, Maria, Filocamo, Giovanni, Cattalini, Marco, Taddio, Andrea, Caorsi, Roberta, Marseglia, Gian Luigi, La Torre, Francesco, Campana, Andrea, Simonini, Gabriele, Ravelli, Angelo, Montin, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478576/ https://www.ncbi.nlm.nih.gov/pubmed/37675397 http://dx.doi.org/10.3389/fped.2023.1137051

Ejemplares similares

MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2021)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2022)

Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics
por: Cattalini, Marco, et al.
Publicado: (2021)

Multi-Inflammatory Syndrome in Children (MIS-C) in 2023: Is It Time to Forget about It?
por: La Torre, Francesco, et al.
Publicado: (2023)

The off-label use of anakinra in pediatric systemic autoinflammatory diseases
por: Maniscalco, Valerio, et al.
Publicado: (2020)

Discordance between Clinical and Ultrasound Examinations in Juvenile Idiopathic Arthritis: An Experimental Approach
por: Licciardi, Francesco, et al.
Publicado: (2022)

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey
por: Cattalini, Marco, et al.
Publicado: (2021)

Cardiac MRI in midterm follow-up of MISC: a multicenter study
por: Benvenuto, Simone, et al.
Publicado: (2022)

Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)

Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review
por: Maniscalco, Valerio, et al.
Publicado: (2023)

Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids
por: Cattaneo, Paolo, et al.
Publicado: (2021)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Bhat, Chandrika S., et al.
Publicado: (2021)

Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report
por: La Torre, Francesco, et al.
Publicado: (2023)

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020)

Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
por: Della Paolera, Sara, et al.
Publicado: (2021)

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
por: Çaǧlayan, Şengül, et al.
Publicado: (2022)

Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age
por: Campanello, Claudia, et al.
Publicado: (2022)

Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score
por: Brisca, Giacomo, et al.
Publicado: (2021)

Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
por: Pontali, Emanuele, et al.
Publicado: (2021)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

Use of anakinra in severe COVID-19: A case report
por: Filocamo, Giovanni, et al.
Publicado: (2020)

Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
por: Mariani, Marcello, et al.
Publicado: (2022)

Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2014)

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease
por: Marchesi, Alessandra, et al.
Publicado: (2021)

First diagnosis of multisystem inflammatory syndrome in children (MIS-C): an analysis of PoCUS findings in the ED
por: Delmonaco, Angelo G., et al.
Publicado: (2021)

Neuro-PIMS-TS: a single case report and review of the literature
por: Scarcella, Antonio, et al.
Publicado: (2022)

Case Report: Simil-Appendicitis Presentation May Precede Cardiac Involvement in MIS-C Patient
por: Trevisan, Matteo, et al.
Publicado: (2022)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2
por: Castagnola, Elio, et al.
Publicado: (2021)

Incidence and Prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C) in Southern Italy †
por: La Torre, Francesco, et al.
Publicado: (2023)

Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports
por: Mastrolia, Maria Vincenza, et al.
Publicado: (2021)

Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review
por: Trapani, Sandra, et al.
Publicado: (2022)

12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
por: Paloni, G, et al.
Publicado: (2008)

Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report
por: Cicalese, Maria Pia, et al.
Publicado: (2018)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011)

The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?
por: Pagnini, Ilaria, et al.
Publicado: (2021)

A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review
por: Maccora, Ilaria, et al.
Publicado: (2023)

Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy in Two Siblings: Same Mutations but Very Different Phenotypes
por: Carpino, Andrea, et al.
Publicado: (2021)

PW01-039 – Long-term efficacy of anakinra in SoJIA patients
por: Naselli, A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dmvm2hpj04b703kdojb39muc0r